(Total Views: 532)
Posted On: 07/05/2025 7:03:56 PM
Post# of 155201
Go to # 0128
Embodiments include dosages in amounts ranging from about 175 mg to about 1,400 mg, including dosage forms delivering certain amounts of the CCR5 binding agent such as 175 mg, 350 mg, 525 mg, 700 mg, 875 mg, 1050 mg, 1,225 mg, and 1,400 mg.
Continues into # 0129, etc...
The above is only due to mentioned weeks ago seeing 1400 mg ever mentioned in a patent
___
I digressed......:
[0166] The summary of results for CCR5 expression and PD-L1 expression is as follows:
(Keep in mind, they are LL 350 mg)
Results starting @ # 0163
700 mg really going to be an industry game changer.
https://www.patentguru.com/assignee/cytodyn-inc
Embodiments include dosages in amounts ranging from about 175 mg to about 1,400 mg, including dosage forms delivering certain amounts of the CCR5 binding agent such as 175 mg, 350 mg, 525 mg, 700 mg, 875 mg, 1050 mg, 1,225 mg, and 1,400 mg.
Continues into # 0129, etc...
The above is only due to mentioned weeks ago seeing 1400 mg ever mentioned in a patent
___
I digressed......:
[0166] The summary of results for CCR5 expression and PD-L1 expression is as follows:
(Keep in mind, they are LL 350 mg)
Results starting @ # 0163
700 mg really going to be an industry game changer.
https://www.patentguru.com/assignee/cytodyn-inc
(4)
(0)
